AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 156, Issue -, Pages 113942
Publisher
Elsevier BV
Online
2022-10-28
DOI
10.1016/j.biopha.2022.113942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
- (2022) Bo Mi Ku et al. INVESTIGATIONAL NEW DRUGS
- Fatty acid synthase: a druggable driver of breast cancer brain metastasis
- (2022) Javier A. Menendez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
- (2022) Mohammad-Javad Sanaei et al. Translational Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Modulation of LXR signaling altered the dynamic activity of human colon adenocarcinoma cancer stem cells in vitro
- (2021) Hassan Dianat-Moghadam et al. Cancer Cell International
- Review on target domains and natural compound‐based inhibitors of fatty acid synthase for anticancer drug discovery
- (2021) Lakshmi Soukya Sai Pulla et al. Chemical Biology & Drug Design
- Sulforaphane downregulated fatty acid synthase and inhibited microtubule-mediated mitophagy leading to apoptosis
- (2021) Yuting Yan et al. Cell Death & Disease
- Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models
- (2020) Emma Polonio-Alcalá et al. Cancers
- Molecular profiling of non-small cell lung cancer
- (2020) Marika L. Forsythe et al. PLoS One
- AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
- (2019) Hirokazu Taniguchi et al. Nature Communications
- EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models
- (2019) Ariadna Giró-Perafita et al. MOLECULES
- Preparative isolation and purification of steroidal glycoalkaloid from the ripe berries of Solanum nigrum L. by preparative HPLC‐MS and ultra high performance liquid chromatography time‐of‐flight‐MS/MS and its anti‐non‐small cell lung tumours effects in vitro and in vivo
- (2019) Fengqiang Shi et al. JOURNAL OF SEPARATION SCIENCE
- Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway
- (2019) Ligong Chang et al. Lipids in Health and Disease
- MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer
- (2019) Qiming Wang et al. Journal of Hematology & Oncology
- Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
- (2018) Azhar Ali et al. EMBO Molecular Medicine
- EGFR-TKIs resistance via EGFR-independent signaling pathways
- (2018) Qian Liu et al. Molecular Cancer
- (−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
- (2018) Joan Crous-Masó et al. MOLECULES
- STAT3 signaling mediates tumour resistance to EGFR targeted therapeutics
- (2017) Ahmad A. Zulkifli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
- (2017) Kirstine Jacobsen et al. Nature Communications
- Sulforaphane Induced Apoptosis via Promotion of Mitochondrial Fusion and ERK1/2-Mediated 26S Proteasome Degradation of Novel Pro-survival Bim and Upregulation of Bax in Human Non-Small Cell Lung Cancer Cells
- (2017) Yang Geng et al. Journal of Cancer
- Mechanistic Study of Bakuchiol-Induced Anti-breast Cancer Stem Cell and in Vivo Anti-metastasis Effects
- (2017) Li Li et al. Frontiers in Pharmacology
- The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer
- (2016) Victoria M. Youngblood et al. CANCER RESEARCH
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- Osimertinib: First Global Approval
- (2016) Sarah L. Greig DRUGS
- A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
- (2016) Li Yang et al. Oncotarget
- Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells
- (2015) Maria Theresa E. Montales et al. Genes and Nutrition
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation
- (2015) Lakshmi Reddy Bollu et al. Oncotarget
- Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells
- (2015) Maria Theresa E. Montales et al. Genes and Nutrition
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- Lung Cancer Stem Cells and Implications for Future Therapeutics
- (2014) Jing Wang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor
- (2014) M. Raymond V. Finlay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lung cancer stem cells: Molecular features and therapeutic targets
- (2013) Sandeep Singh et al. MOLECULAR ASPECTS OF MEDICINE
- Afatinib Prolongs Survival Compared with Gefitinib in an Epidermal Growth Factor Receptor-Driven Lung Cancer Model
- (2013) T. Ninomiya et al. MOLECULAR CANCER THERAPEUTICS
- Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer
- (2012) Joana Relat et al. BMC CANCER
- Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway
- (2012) A. B. Cortot et al. CANCER RESEARCH
- (−)-Epigallocatechin Gallate Induces Fas/CD95-Mediated Apoptosis through Inhibiting Constitutive and IL-6-Induced JAK/STAT3 Signaling in Head and Neck Squamous Cell Carcinoma Cells
- (2012) Hui-Yi Lin et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy
- (2012) Madhuri Sankaranarayanapillai et al. MOLECULAR IMAGING AND BIOLOGY
- EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer
- (2012) Su-Ni Tang et al. PLoS One
- Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
- (2012) K. Ohashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- Increased Fatty Acid Synthase Activity in Non-small Cell Lung Cancer Tissue Is a Weaker Predictor of Shorter Patient Survival than Increased Lipoprotein Lipase Activity
- (2010) Darko Cerne et al. ARCHIVES OF MEDICAL RESEARCH
- Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
- (2009) Rafael Rosell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors
- (2008) H. Orita et al. CLINICAL CANCER RESEARCH
- EGFR Mutations in Lung Adenocarcinomas
- (2008) Allan R. Li et al. JOURNAL OF MOLECULAR DIAGNOSTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now